Stefan Blochlinger

Showing 1-2 of 2 articles

Coronary interventions

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Mueller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S

December 9, 2016 | 10.4244/EIJY15M12_09

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials

Taniwaki M, Stefanini G, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostojic M, Hernández-Antolín R, Baumbach A, Blochlinger S, Jüni P, Mainar V, Sabaté M, Windecker S

August 20, 2015 | 10.4244/EIJY14M07_12

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Ahead of print: Transcatheter treatment of multivalvular heart disease

Cardioband after placement of 17 screws before and after

Balancing risks and benefits of LM revascularisation strategies in CKD patients

Gennaro Giustino

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Contained annulus ruptures – the price to pay for optimal haemodynamic results?

Fabian Nietlispach

This week's JAA's: Right pulmonary artery to left atrium fistula, BRS in high-risk patients

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke